Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis
2019 · BMC Cancer · 38 citations
https://doi.org/10.1186/s12885-019-6132-0
M
Mingxia Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
249
Papers
2.8K
Citations
26
h-index
69
i10-index
Mingxia Wang is an academic researcher from Qiqihar Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Advanced biosensing and bioanalysis techniques & Electrochemical sensors and biosensors. The author has an h-index of 26, co-authored 212 publications.
ORCID: 0000-0003-2340-8941Papers by this author
worksCRISPR applications in cancer diagnosis and treatment
2023 · Cellular & Molecular Biology Letters · 22 citations
https://doi.org/10.1186/s11658-023-00483-4
Intravenous Lidocaine Significantly Reduces the Propofol Dose in Elderly Patients Undergoing Gastroscopy: A Randomized Controlled Trial
2022 · Drug Design Development and Therapy · 17 citations
https://doi.org/10.2147/dddt.s377237
HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial
2024 · Nature Communications · 17 citations
https://doi.org/10.1038/s41467-024-48798-w
Characterisation and comparison of enzymatically prepared donkey milk whey protein hydrolysates
2024 · Food Chemistry X · 15 citations
https://doi.org/10.1016/j.fochx.2024.101360
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer
2023 · Nature Communications · 12 citations
https://doi.org/10.1038/s41467-023-39139-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat